title: Vismodegib as eye-sparing adjuvant treatment for orbital basal cell carcinoma.
authors.affiliation: Eye Plastic and Orbital Surgery Service, Department of Ophthalmology and Visual Sciences, Kellogg Eye Center, University of Michigan, Ann Arbor.
authors.forename: Alon
authors.initials: A
authors.lastname: Kahana
authors.forename: Francis P
authors.initials: FP
authors.lastname: Worden
authors.forename: Victor M
authors.initials: VM
authors.lastname: Elner
mesh_terms: D000284:Administration, Oral; D000368:Aged; D000813:Anilides / Q000627:therapeutic use*; D000970:Antineoplastic Agents / Q000627:therapeutic use*; D001706:Biopsy; D002280:Basal Cell Carcinoma / Q000188:drug therapy* / Q000473:pathology / Q000601:surgery; D017024:Chemotherapy, Adjuvant; D053823:Hedgehog Proteins / Q000037:antagonists & inhibitors; D006801:Humans; D008279:Magnetic Resonance Imaging; D008297:Male; D013508:Ophthalmologic Surgical Procedures; D009918:Orbital Neoplasms / Q000188:drug therapy* / Q000473:pathology / Q000601:surgery; D011725:Pyridines / Q000627:therapeutic use*
chemical_list: D000813:Anilides; D000970:Antineoplastic Agents; D053823:Hedgehog Proteins; C538724:HhAntag691; D011725:Pyridines
references.citation: N Engl J Med. 2012 Jun 7;366(23):2225-6
references.pmid: 22670909
references.citation: N Engl J Med. 2012 Jun 7;366(23):2180-8
references.pmid: 22670904
references.citation: N Engl J Med. 2012 Jun 7;366(23):2171-9
references.pmid: 22670903
references.citation: Am J Ophthalmol. 2012 Feb;153(2):238-241.e1
references.pmid: 21982108
references.citation: Ophthalmology. 2005 Apr;112(4):717-23
references.pmid: 15808267